Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008

WALTHAM, Mass., May 26 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming FBR Capital Markets 12th Annual Spring Investor Conference being held May 28, 2008 at the Grand Hyatt in New York. Ron Geraty, President, Health Management, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Wednesday, May 28, 2008 at 9:45 a.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and through FBR's website at
An investor presentation to be provided at the conference will be made available to the public on the company's website via the link provided above.

Inverness Medical Innovations is a leading global developer of advanced diagnostic devices and is presently exploring new opportunities for its proprietary electrochemical and other technologies in a variety of professional diagnostic and consumer-oriented applications including immuno- diagnostics with a focus on women's health, cardiology and infectious disease. The Company's new product development efforts, as well as its position as a leading supplier of consumer pregnancy and fertility/ovulation tests and rapid point-of-care diagnostics, are supported by the strength of its intellectual property portfolio. Inverness is headquartered in Waltham, Massachusetts.

First Call Analyst:
FCMN Contact: leydenberkshire@earthlink.net

Source: Inverness Medical Innovations, Inc.

CONTACT: Doug Guarino, Director of Corporate Relations of Inverness
Medical Innovations, Inc., +1-781-647-3900

Web site: http://www.invmed.com/investors.cfm
http://www.wsw.com/webcast/fbr21/ima

2008-05-26 11:29:56 0370083 PRNEWSWIRE